Poolbeg and AnaBio secure €2.3m for vaccine trial

Companies plan to develop oral vaccine platform

Dr Sinéad B. Bleiel, founder and director of AnaBio Technologies based in Carrigtowhill. Her company is focused on the microencapsulation of sensitive bioactive ingredients. Picture: Brendan Lyon

Infectious disease specialists Poolbeg Pharma has announced the consortium its runs with Cork firm AnaBio has been awarded €2.3m in grant funding to progress its platform to create new oral vaccines 

Taking place over three years, the collaboration called EncOVac between Poolbeg Pharma, University College Dublin, Trinity College Dublin and AnaBio Technologies will result in the development of an oral vaccine candidate to a Phase I ready state. The resulting technology will then serve as a platform for additional oral vaccine candidates for a wide range of pathogens, initially targeting bacterial infections.